65 related articles for article (PubMed ID: 6187640)
1. [Preparation and characterization of an antithrombin III concentrate].
Dornheim G; Schön R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):870-7. PubMed ID: 6187640
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of prothrombin complex concentrates with reduced thrombogenicity].
Dornheim G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):856-62. PubMed ID: 6187638
[TBL] [Abstract][Full Text] [Related]
3. A pasteurized antithrombin III concentrate for clinical use.
Smith JK; Winkelman L; Evans DR; Haddon ME; Sims G
Vox Sang; 1985; 48(6):325-32. PubMed ID: 4013136
[TBL] [Abstract][Full Text] [Related]
4. Commercial antithrombin concentrate contains inactive L-forms of antithrombin.
Chang WS; Harper PL
Thromb Haemost; 1997 Feb; 77(2):323-8. PubMed ID: 9157590
[TBL] [Abstract][Full Text] [Related]
5. [Isolation and characteristics of antithrombin III from human plasma].
Markova OA; Kalashnikov VV; Khvatov VB
Vopr Med Khim; 1987; 33(3):62-6. PubMed ID: 3630019
[TBL] [Abstract][Full Text] [Related]
6. Development of large scale fractionation methods. VII. Preparation of antithrombin III concentrate.
Wickerhauser M; Williams C; Mercer J
Vox Sang; 1979; 36(5):281-93. PubMed ID: 462917
[TBL] [Abstract][Full Text] [Related]
7. [The effect of substitution with AT III- and PPSB-concentrates in patients with terminal liver insufficiency].
Scherer R; Gille A; Erhard J; Paar D; Kox WJ
Anaesthesist; 1994 Mar; 43(3):178-82. PubMed ID: 8179167
[TBL] [Abstract][Full Text] [Related]
8. [Prophylactic use of concentrated antithrombin III preparation in children with nephrotic syndrome].
Oikawa T; Muramatsu Y; Akashi S; Usui N
Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1163-9. PubMed ID: 8264106
[TBL] [Abstract][Full Text] [Related]
9. [Procedures for the isolation and characterization of human antithrombin III].
Trobisch H; Wüst T; Rustige H
Behring Inst Mitt; 1986 Feb; (79):177-90. PubMed ID: 3718405
[TBL] [Abstract][Full Text] [Related]
10. Comparison of membrane adsorber (MA) based purification schemes for the down-stream processing of recombinant h-AT III.
Reif OW; Freitag R
Bioseparation; 1994 Dec; 4(6):369-81. PubMed ID: 7765681
[TBL] [Abstract][Full Text] [Related]
11. The preparation of specific sorbents with polyclonal antibodies as a ligand for purification of human antithrombin III.
Rogalski J; Dawidowicz AL; Wiater A; Gibuła K; Winiarczyk S
Acta Microbiol Pol; 1998; 47(2):153-65. PubMed ID: 9839374
[TBL] [Abstract][Full Text] [Related]
12. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma.
Zhao Y; Zhao R; Shangguan D; Xiong S; Liu G
Biomed Chromatogr; 2001 Dec; 15(8):487-92. PubMed ID: 11748680
[TBL] [Abstract][Full Text] [Related]
13. [Antithrombin III in hip surgery].
Weber U; Schöndorf TH; Rettig H
Z Orthop Ihre Grenzgeb; 1984; 122(1):16-9. PubMed ID: 6702257
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
15. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
Takahashi HK; Nader HB; Dietrich CP
Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of guinea pig antithrombin III.
Clement LT
Prep Biochem; 1983; 13(1):1-20. PubMed ID: 6856582
[TBL] [Abstract][Full Text] [Related]
17. [Studies on antithrombin III. I. Purification and some properties of antithrombin III (ATIII), and the relationship between plasma antithrombin activity and ATIII antigen concentration (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):879-88. PubMed ID: 7234301
[No Abstract] [Full Text] [Related]
18. Preparation of anhydro-thrombin and its interaction with plasma antithrombin III.
Tomono T; Sawada E
Nihon Ketsueki Gakkai Zasshi; 1986 Jul; 49(4):969-79. PubMed ID: 3766081
[No Abstract] [Full Text] [Related]
19. Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography.
Biescas H; Gensana M; Fernández J; Ristol P; Massot M; Watson E; Vericat F
Haematologica; 1998 Apr; 83(4):305-11. PubMed ID: 9592979
[TBL] [Abstract][Full Text] [Related]
20. Purification and properties of guinea pig antithrombin III.
Heck L; Rosenberg R; Remold H
Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
